PA
EVH icon

Perceptive Advisors’s Evolent Health EVH Stock Holding History

Perceptive Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-50,000
Closed -$190K – 145
2017
Q1 		$190K Buy
+50,000
New +$960K 0.01% 135

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Perceptive Advisors's EVH Position: Q2 2022 in Review

Perceptive Advisors sold out of Evolent Health (EVH) in Q2 2022, closing a stake of 250,000 shares — an estimated $8.07M sold.

Perceptive Advisors first reported a position in EVH in Q2 2015 and held it in 14 quarters. The position peaked at $32.2M in Q1 2017. 215 funds tracked by Wall St. Rank hold EVH as of Q2 2022.

  • Perceptive Advisors reported no remaining Evolent Health position as of Q2 2022 after selling out during the quarter.
  • Perceptive Advisors sold 250,000 Evolent Health shares in Q2 2022, an estimated $8.07M.
  • Perceptive Advisors first reported a position in Evolent Health in Q2 2015 and held it in 14 quarters.
  • Perceptive Advisors's Evolent Health position peaked at $32.2M in Q1 2017.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q2 2022.

Based on Perceptive Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.